Oxford Nanopore CTO to present at AGBT conference in Florida

Oxford Nanopore Technologies Ltd. announces that Clive G Brown, Chief Technology Officer, will present at the Advances in Genome Biology and Technology (AGBT) conference in Marco Island, Florida, on 17th February 2012 at 11.40am (EST) / 4.40pm (GMT).

The talk is titled: "Single Molecule 'Strand' Sequencing Using Protein Nanopores and Scalable Electronic Devices".

Oxford Nanopore intends to commercialise DNA strand sequencing products, directly to customers within 2012. At the AGBT presentation, Oxford Nanopore will show DNA strand sequencing data and other disruptive features of the Company's proprietary electronics-based sensing devices.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Oxford Nanopore Technologies. (2019, June 20). Oxford Nanopore CTO to present at AGBT conference in Florida. News-Medical. Retrieved on May 10, 2024 from https://www.news-medical.net/news/20120202/Oxford-Nanopore-CTO-to-present-at-AGBT-conference-in-Florida.aspx.

  • MLA

    Oxford Nanopore Technologies. "Oxford Nanopore CTO to present at AGBT conference in Florida". News-Medical. 10 May 2024. <https://www.news-medical.net/news/20120202/Oxford-Nanopore-CTO-to-present-at-AGBT-conference-in-Florida.aspx>.

  • Chicago

    Oxford Nanopore Technologies. "Oxford Nanopore CTO to present at AGBT conference in Florida". News-Medical. https://www.news-medical.net/news/20120202/Oxford-Nanopore-CTO-to-present-at-AGBT-conference-in-Florida.aspx. (accessed May 10, 2024).

  • Harvard

    Oxford Nanopore Technologies. 2019. Oxford Nanopore CTO to present at AGBT conference in Florida. News-Medical, viewed 10 May 2024, https://www.news-medical.net/news/20120202/Oxford-Nanopore-CTO-to-present-at-AGBT-conference-in-Florida.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Science journal’s NEWSFOCUS section describes recent advances in sequencing technology